Fc Receptors recombinant protein (Austin Research Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFc Receptors recombinant protein (Austin Research Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFc receptors agonists
TargetsFc receptors
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicThrombocytopenia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAustin Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotech AustraliaAustin Research Institute
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicThrombocytopenia +[5] 

Other Information

ATC CodeN/A
Related LinksN/A